Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07262255

WATCHMAN FLX Pro European Registry

Led by Boston Scientific Corporation · Updated on 2026-05-08

1000

Participants Needed

11

Research Sites

141 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LAAC Access Solution.

CONDITIONS

Official Title

WATCHMAN FLX Pro European Registry

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is planned to be treated with the WATCHMAN FLX Pro LAAC device
  • Patient has non-valvular atrial fibrillation and is clinically indicated for the WATCHMAN FLX Pro device per Instructions for Use
  • Patient or legal representative is willing and able to provide informed consent
  • Patient is able and willing to attend required follow-up visits and examinations
  • Patient is 18 years or older or of legal consenting age according to local laws
Not Eligible

You will not qualify if you...

  • Patient has a documented life expectancy of less than 12 months
  • Patient is currently enrolled in another investigational study or registry, except mandatory governmental or purely observational registries
  • Presence of intracardiac thrombus (blood clot in the heart)
  • Presence of an atrial septal defect repair or closure device or a patent foramen ovale repair or closure device
  • Left atrial appendage anatomy unsuitable for closure device
  • Known hypersensitivity or contraindications as described in the device Instructions for Use
  • Female patient of childbearing potential who is pregnant or plans to become pregnant during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 11 locations

1

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

2

Rigshospitalet Copenhagen

Copenhagen, Denmark, 2100

Actively Recruiting

3

Kath Krankenhaus St Johann Nepomuk

Erfurt, Germany, 99097

Actively Recruiting

4

Asklepios Klinik Saint Georg

Hamburg, Germany, 20099

Actively Recruiting

5

Asklepios Klinik Nord Heidberg

Hamburg, Germany, 22417

Actively Recruiting

6

Asklepios Klinik Altona

Hamburg, Germany, 22763

Actively Recruiting

7

Centro Cardiologico Monzino

Milan, Italy, 20138

Actively Recruiting

8

Hospital de Leon

León, Spain, 24071

Actively Recruiting

9

Clinica Universidad de Navarra

Pamplona, Spain, 31008

Actively Recruiting

10

University Hospital Basel

Basel, Switzerland, 4031

Actively Recruiting

11

INSELSPITAL - Universitätsspital Bern

Bern, Switzerland, CH-3010

Actively Recruiting

Loading map...

Research Team

T

Thomas Näschen, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

WATCHMAN FLX Pro European Registry | DecenTrialz